OTC Version of Flonase Approved by FDA

GlaxoSmithKline announced that the FDA has approved Flonase Allergy Relief (fluticasone propionate 50mcg spray) as a once-daily over-the-counter (OTC) treatment indicated for symptoms of seasonal and perennial allergic and nonallergic rhinitis in patients ≥4 years of age

Number of Uninsured Down After ACA Open Enrollment

There has been a decrease in the number of uninsured following the open enrollment period of the Affordable Care Act (ACA).

Good Odds for Bone Marrow Donor Matching

Most suitable candidates in the United States who need a bone marrow transplant can find an acceptable match through the National Marrow Donor Program, according to a new study.

Shared Medical Appointments Get High Marks from Patients

Shared medical appointments (SMAs) improve patient satisfaction with primary care.

No Pregnancy Impact with HIV Preexposure Prophylaxis

For HIV-serodiscordant couples, preexposure prophylaxis (PrEP) does not impact pregnancy incidence or outcomes.

Addressing Gynecologic Concerns in Young Cancer Patients

Young cancer patients and survivors may have gynecologic concerns, which should be managed before, during, and after treatment.